Expert: Professor Daniela Krause Director of the Institute of Transfusion Medicine at the University of Mainz  (Germany)

Program:
Overview of significant biological aspects presented during the meeting, including:

• New therapeutic concepts in CML (01:50)
  • SSRI paroxetine targets both c-Myc-dependent and inflammatory CML LSC (01:59)
  • PROTAC-based BCR::ABL1 degrader (03:07)
  • New antibody treatment against CD47 (04:31)
• Bone marrow microenvironment (05:38)
• Biological factors and biomarkers impacting treatment-free remission (08:40)
• Leukemic stem cells - new ways of targeting (10:33)
• Metabolism in leukemic stem cells (11:27)
• Novel developments in HSC transplant and treatment of GVHD (12:15)
• The role of defective neutrophil clearance in MPN (13:00)
• Interesting presentations from areas outside of CML (13:35)
• Workshop on imaging (17:04)
• Workshop on single-cell analysis (19:45)
  
  
• Q&A Session (21:36)

If you have any questions or comments to the speaker, please email info@cml-foundation.org.